Press release
Acute Pancreatitis Market expected to reach USD 7372.01 Million By 2025 at CAGR of 5.91%
Acute Pancreatitis Market is estimated to be valued at USD 7372.01 Million by 2025 and is expected to register a CAGR of 5.91% during the forecast period. There are several other reasons, such as heavy alcohol consumption, ingested medicines, and others that cause acute pancreatitis. The rising prevalence of gallstones and high consumption of alcohol is driving the global acute pancreatitis market. However, stringent regulations imposed by the FDA (Food and Drug Administration) are expected to hamper the growth of this market.Acute pancreatitis is a condition where the pancreas becomes inflamed. The most common cause of acute pancreatitis is stones in the gallbladder. Acute pancreatitis is the single-most frequent gastrointestinal cause for hospital admissions in the US, with nearly 275,000 hospitalizations annually.
Market Players
Market Research Future (MRFR) recognizes CalciMedica, SCM Lifescience, Samsung Bioepis, GNT Pharma Co., Baxter International Inc., B. Braun Melsungen AG, General Electric Company, Medtronic, Boston Scientific Corporation, and Fresenius Kabi USA as the key players in the Global Acute Pancreatitis Market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1565
Segment Analysis
The Global Acute Pancreatitis Market has been segmented into Cause, Treatment & Diagnosis, and End User.
Based on the cause, the global acute pancreatitis market has been segmented into gallstones, alcohol, and others. The gallstones segment accounted for the largest market share of 49.52% in 2018 and is expected to exhibit a CAGR of 5.88% by the end of the forecast period. Rising cases of gall stones worldwide and growing older population along with hereditary predispositions are major risk factors causing gall stones, which is driving the growth of the acute pancreatitis market. For instance, according to the World Gastroenterology Organization, about 20 million people in the USA (15% of the population) had gallstones in 2016.
On the basis of treatment & diagnosis, the global acute pancreatitis market has been segregated into treatment and diagnosis. The treatment segment is further classified as intravenous fluid, nutritional support, analgesics, endoscopic retrograde cholangiopancreatography (ERCP), and others. The diagnosis segment is further classified as imaging tests and laboratory tests.
On the basis of end-user, the global acute pancreatitis market has been segmented into hospitals & clinics and others.
Regional Analysis
The Global Acute Pancreatitis Market has been segmented based on region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The increasing prevalence of gall stones and alcohol consumption among the population and the availability of advanced healthcare facilities in the US and Canada are likely to support the dominance of the Americas on this market during the forecast period. Additionally, the rising geriatric population increases the rate of prevalence of gallstones as they are more susceptible to diseases. The increasing incidence of acute pancreatitis has led to a rise in the demand for advanced and effective diagnostic tests and treatment options.
Key Findings of the Study:
The Global Acute Pancreatitis Market is projected to reach over USD 7372.01 Million by 2025 at a 91% CAGR during the review period of 2019 to 2025.
Americas accounted for the largest market share with the US being the major contributor to the growth of the market.
By cause, the gallstones segment is projected to register the largest market share of 49.52% during the forecast period. According to a recent research study by the Dutch Pancreatitis Study Group, the most common cause of acute pancreatitis in Europe and North America is gall bladder.
Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/acute-pancreatitis-market-1565
Related Reports:
https://healthcaretrendingnews.wordpress.com/2022/01/13/protein-engineering-market-astonishing-growth-with-top-influencing-key-players/
https://healthcaretrendingnews.wordpress.com/2022/01/13/gene-editing-market-2020-global-industry-exhibits-huge-growth-by-top-key-players/
https://healthcaretrendingnews.wordpress.com/2022/01/13/antibody-drug-conjugate-market-in-global-industry-demands-insights-research-and-forecast-2020-2027/
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York, New York 10013,
United States of America
+1 646 845 9312
Email: sales@marketresearchfuture.com
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Pancreatitis Market expected to reach USD 7372.01 Million By 2025 at CAGR of 5.91% here
News-ID: 2526265 • Views: …
More Releases from Market Research Future (MRFR)

Tofu Market to Reach USD 2.7 Billion by 2032 at 9.01% CAGR Driven by Rising Plan …
The global tofu market is poised for substantial growth over the next decade, projected to reach an impressive valuation of USD 2.7 billion by 2032. This expansion reflects a compound annual growth rate (CAGR) of 9.01% from 2024 to 2032, fueled by a surge in consumer demand for plant-based foods and an evolving global food culture. As more consumers seek healthier and sustainable alternatives to animal-based protein sources, tofu has…

Plant-Based Food Ingredients Market to Hit USD 40.2 Billion by 2035 at 7.96% CAG …
The global plant-based food ingredients market is witnessing remarkable growth, propelled by an increasing shift in consumer preferences toward healthier and more sustainable food options. According to recent market research by Market Research Future, the market was valued at USD 16.03 billion in 2023 and is projected to reach an impressive USD 40.2 billion by 2035. This growth trajectory is expected to continue at a compound annual growth rate (CAGR)…

Semolina Market to Reach USD 2.57 Billion by 2032 at 2.31% CAGR, Driven by Healt …
The global semolina market is poised for steady growth over the coming decade, with its valuation expected to reach USD 2.57 billion by 2032. According to the latest Market Research Future analysis, the market was valued at USD 2.12 billion in 2023 and is projected to expand from USD 2.14 billion in 2024 to USD 2.57 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.31% during the…

Ginger Extract Market to Reach USD 2.18 Billion by 2034 at 5.4% CAGR Driven by D …
The global ginger extract market is poised for substantial growth in the coming decade, with a projected valuation of USD 2.18 billion by 2034. According to the latest analysis from Market Research Future, the market was valued at USD 1.29 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2034. This robust growth trajectory is largely fueled by increasing…
More Releases for Acute
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,…
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market
Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but…
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…